Cargando…
A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada
BACKGROUND: This paper will determine whether expanding Insite (North America’s first and only supervised injection facility) to more locations in Canada such as Montreal, cost less than the health care consequences of not having such expanded programs for injection drug users. METHODS: By analyzing...
Autores principales: | Jozaghi, Ehsan, Reid, Andrew A, Andresen, Martin A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710233/ https://www.ncbi.nlm.nih.gov/pubmed/23837814 http://dx.doi.org/10.1186/1747-597X-8-25 |
Ejemplares similares
-
A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada
por: Jozaghi, Ehsan, et al.
Publicado: (2014) -
A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada
por: Jozaghi, Ehsan
Publicado: (2014) -
Should North America’s first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?
por: Jozaghi, Ehsan, et al.
Publicado: (2013) -
Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility
por: Irwin, Amos, et al.
Publicado: (2017) -
Exploring the role of an unsanctioned, supervised peer driven injection facility in reducing HIV and hepatitis C infections in people that require assistance during injection
por: Jozaghi, Ehsan
Publicado: (2015)